Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HBB | P68871 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18325718 | 0.80 | MAT2A (0.37) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL9124222 | 0.79 | DPYD (0.31) | — | |
| SCHEMBL22500804 | 0.76 | ALDH1A1 (0.34) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL1225985 | 0.76 | GDA (0.36) | ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL27244201 | 0.76 | PGK1 (0.33) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL12894751 | 0.73 | ALDH1A1 (0.32) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL4183696 | 0.73 | — | — | |
| SCHEMBL27252703 | 0.72 | ALDH1A1 (0.31) | ALDH1A1LMNAMAPTCYP19A1TSHR | |
| SCHEMBL2221557 | 0.72 | ADORA3 (0.41) | ALDH1A1LMNAMAPTTSHRHTT | |
| SCHEMBL12104174 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-05-27 | — | — | US | claimed |
| EP-2137201-A2 | PROCESS FOR PREPARING CAPECITABINE | Dr. Reddy's Laboratories Ltd. (IN) | 2009-12-30 | — | — | EP | claimed |
| WO-2008131062-A2 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-10-30 | — | — | WO | claimed |
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-05-27 | — | — | US | disclosed |
| EP-2137201-A2 | PROCESS FOR PREPARING CAPECITABINE | Dr. Reddy's Laboratories Ltd. (IN) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008131062-A2 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DPYD, TYMP, TYMS | ALDH1A1 1748/4885LMNA 2171/4885MAPT 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.